Atlas Trials

Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)

Clinical trial NCT00651378 · TERMINATED

Trial details

NCT number
NCT00651378
Sponsor
Organon and Co
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
HypercholesterolemiaAtherosclerosisCoronary Artery Disease
Start date
2004-09-01
Primary completion
2005-06-01
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.